Bhisham Chera, MD

Associate Professor; Associate Chair of Clinical Operations and Improvement; Director of Patient Safety and Quality

Dr. Bhisham Chera


Office: (984) 974-0400
Fax:  (984) 974-8607


Head and Neck Oncology
Skin Cancer


MD Medical University of South Carolina, Charleston, SC (2000 - 2004)

Residency - Department of Radiation Oncology, University of Florida Shands Cancer Center Gainesville, FL (2005 - 2009)

BS (Biology) Winthrop University, Rock Hill, SC (1997 - 2000)

Board Certifications

ABR Board Certified in Radiation Oncology (2010)
ABR Oral Boards, Passed (2010)
ABR Clinical Written Boards, Passed (2009)

ABR Radiobiology and Physics Written Boards, Passed (2008)
USMLE Step 3, Passed (2004)
USMLE Step 2, Passed (2003)
USMLE Step 1, Passed (2002)

Academic Honors and Awards

2017     UNC Health Care and Faculty Physicians Award for Carolina Care Excellence

2016     UNC Health Care and Faculty Physicians Award for Carolina Care Excellence

2015     ARRO Educator of the Year

2015     UNC Radiation Oncology Excellence in Teaching Award

2015     UNC Health Care and UNC Faculty Physicians Award for Carolina Care Excellence

2014     UNC Radiation Oncology Excellence in Teaching Award

2012     UNC Radiation Oncology Excellence in Teaching Award

2011     NIH Loan Repayment Program

2009     University of Florida/Shands Hospital Resident Teacher Award

2009     Roentgen Resident/Fellow Research Award

2001–2004     M. Gordon Howle, MD Scholarship

2001–2004     Rich Scholarship

2004     All American Scholar

2004     Alpha Omega Alpha

2004     Thomas Holbrook Award

2002     Distinguished Essay Award Immunology

2001     Health Professions Research Stipend

Grants (Active)

1)    AHRQ, Grant # 1R18HS023458, “Simulation Based Training to Enhance Patient Safety in Radiation Oncology.”  September 2014 to August 2017.  Co-investigator.

2)    NIH, Grant # R 01 CA158925-01, “Integration of Endoscopic and CT Data for Radiation Therapy,” April 2013 to March 2018. Principal Investigator. 

Clinical Trials (Active)

  1. RTOG 1008 (IRB #11-0381). A Randomized Phase II/III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors. Principal Investigator 
  2. LCCC# 1413 (IRB# 14-1795):  De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma.  Principal Investigator.
  3. LCCC # 1612 (IRB # 16-1477):  P53 mutational status and circulating free HPV DNA for the management of HPV-associated Oropharyngeal Squamous Cell Cancers. Principal Investigator.
  4. LCCC # 1430 (IRB# 15-1781):  Phase Ib trial of Dose-escalating AZD1775 in Combination with Concurrent Radiation and Cisplatin for Intermediate and High Risk Head and Neck Squamous Cell Carcinoma (HNSCC). Principal Investigator.


  • Kimple RJ, Chera BS, Harari PF. Chapter 30: General Principles of Radiation Therapy.  Cancer of the Head and Neck. Wolters Kluwer Publisher, pg 706-724 2014. Cancer of the Head and Neck, Fifth edition. Wolters Kluwer. 2017
  • Marks L, Mazur L, Chera B, Adams R.  Engineering Patient Safety in Radiation Oncology.  Productivity Press. March 27th, 2015.  ISBN: 9781482233643.  328 pages.
  • Higginson DS, Cahlon O, Chera BS.  Chapter 5: Advanced Laryngeal Cancer, pg 57-72. Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy.  New York, NY.  Springer. 2015.
  • Chera BS and Mendenhall WM. Chapter 79: Management of Central Nervous System Metastases in Breast Cancer, pg 1297 - 1319. The Breast: Comprehensive Management of Benign and Malignant Diseases, Fourth edition. Atlanta, GA: Elsevier. 2008

Publications/Presentations (.pdf)